dopamine quinone has been researched along with levodopa in 5 studies
| Studies (dopamine quinone) | Trials (dopamine quinone) | Recent Studies (post-2010) (dopamine quinone) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 61 | 0 | 29 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | dopamine quinone (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, M; Miyazaki, I; Ogawa, N | 1 |
| Asanuma, M; Hozumi, H; Miyazaki, I; Miyoshi, K; Sogawa, N | 1 |
| Fujimura, T; Hattoria, N; Kubo, S; Mochizuki, H; Taka, H; Wanga, M; Yoritaka, A | 1 |
| Coleman, RA; Green, RL; Lorenz, AN; Sass, MB | 1 |
| Asanuma, M; Kita, T; Miyazaki, I; Murakami, S; Murata, M; Takeshima, M; Urasoe, N | 1 |
2 review(s) available for dopamine quinone and levodopa
| Article | Year |
|---|---|
Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.
Topics: Animals; Dopamine; Dopamine Agents; Free Radicals; Humans; Levodopa; Monophenol Monooxygenase; Neurotoxicity Syndromes; Parkinson Disease | 2003 |
Toxic effects of dopamine metabolism in Parkinson's disease.
Topics: Aldehydes; alpha-Synuclein; Animals; Dopamine; Humans; Levodopa; Mitochondria; Oxidative Stress; Parkinson Disease | 2009 |
3 other study(ies) available for dopamine quinone and levodopa
| Article | Year |
|---|---|
Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity.
Topics: Animals; Cell Line; Cytoprotection; Dopamine; Dopamine Agents; Levodopa; Metallothionein; Mice; Mice, Knockout; Oxidopamine; Parkinson Disease, Secondary; RNA, Messenger; Zinc | 2007 |
A pragmatic approach to biochemical systems theory applied to an alpha-synuclein-based model of Parkinson's disease.
Topics: alpha-Synuclein; Amyloid; Antiparkinson Agents; Computer Simulation; Dopamine; Gene Expression; Humans; Levodopa; Lewy Bodies; Lysosomes; Models, Neurological; Monoamine Oxidase Inhibitors; Neurotoxins; Parkinson Disease; Proteasome Endopeptidase Complex; Reactive Oxygen Species; Systems Theory; Ubiquitin | 2009 |
Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity.
Topics: Animals; Antioxidants; Antiparkinson Agents; Cell Line; Dopamine; Flavanones; Levodopa; Mice; Neuroprotective Agents; Neurotoxins | 2011 |